The high prices of pioneering gene therapies are forcing urgent discussions around value, affordability and payment methods.
Source: Rollout of high-priced cell and gene therapies forces payer rethink | Nature Biotechnology
The high prices of pioneering gene therapies are forcing urgent discussions around value, affordability and payment methods.
Source: Rollout of high-priced cell and gene therapies forces payer rethink | Nature Biotechnology